Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof

Details for Australian Patent Application No. 2008312641 (hide)

Owner Sanofi-Aventis

Inventors Stengelin, Siegfried; Schwink, Lothar; Hurst, William J.; Czechtizky, Werngard; Gao, Zhongli

Agent Watermark

Pub. Number AU-A-2008312641

PCT Pub. Number WO2009/052068

Priority 60/980,606 17.10.07 US

Filing date 14 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052068 Priority application(s): WO2009/052068

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312653-Amide linked modulators of y-secretase

2008312639-Ore reduction process using carbon based materials having a low sulfur content and titanium oxide and iron metallization product therefrom